Patents by Inventor Dorthe Kot Engelund

Dorthe Kot Engelund has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PROPYLENE GLYCOL-CONTAINING PEPTIDE FORMULATIONS WHICH ARE OPTIMAL FOR PRODUCTION AND FOR USE IN INJECTION DEVICES
    Publication number: 20230364241
    Abstract: The present invention relates to pharmaceutical formulations comprising a peptide and propylene glycol, to methods of preparing such formulations, and to uses of such formulations in the treatment of diseases and conditions for which use of the peptide contained in such formulations is indicated. The present invention further relates to methods for reducing the clogging of injection devices by a peptide formulation and for reducing deposits on production equipment during production of a peptide formulation.
    Type: Application
    Filed: December 9, 2022
    Publication date: November 16, 2023
    Inventors: Tina Bjeldskov Pedersen, Claude Bonde, Dorthe Kot Engelund
  • GLP-1 COMPOSITIONS AND USES THEREOF
    Publication number: 20230093542
    Abstract: The present invention relates to pharmaceutical compositions of the GLP-1 peptide semaglutide comprising no more than 0.1% (w/w) phenol and above 6.4 mg/ml sodium chloride, their preparation, kits comprising such compositions as well as uses thereof.
    Type: Application
    Filed: February 17, 2021
    Publication date: March 23, 2023
    Inventors: Dorthe Kot Engelund, Soeren Snitker, Andrew Mark Louw
  • GLP-1 compositions and uses thereof
    Patent number: 11318191
    Abstract: The present invention relates to pharmaceutical compositions of the GLP-1 peptide semaglutide comprising no more than 0.1% (w/w) phenol and above 6.4 mg/ml sodium chloride, their preparation, kits comprising such compositions as well as uses thereof.
    Type: Grant
    Filed: February 17, 2021
    Date of Patent: May 3, 2022
    Assignee: Novo Nordisk A/S
    Inventors: Dorthe Kot Engelund, Soeren Snitker, Andrew Mark Louw
  • STABLE SEMAGLUTIDE COMPOSITIONS AND USES THEREOF
    Publication number: 20210379159
    Abstract: The present invention relates to pharmaceutical compositions of the GLP-1 peptide semaglutide comprising a stabilizer such as histidine, their preparation, kits comprising such compositions as well as medical uses thereof.
    Type: Application
    Filed: October 25, 2019
    Publication date: December 9, 2021
    Inventors: Dorthe Kot Engelund, Soeren Skov Jensen, Joakim Lundqvist
  • GLP-1 COMPOSITIONS AND USES THEREOF
    Publication number: 20210252111
    Abstract: The present invention relates to pharmaceutical compositions of the GLP-1 peptide semaglutide comprising no more than 0.1% (w/w) phenol and above 6.4 mg/ml sodium chloride, their preparation, kits comprising such compositions as well as uses thereof.
    Type: Application
    Filed: February 17, 2021
    Publication date: August 19, 2021
    Inventors: Dorthe Kot Engelund, Soeren Snitker, Andrew Mark Louw
  • Stable multi-dose compositions comprising an antibody and a preservative
    Patent number: 10835602
    Abstract: The invention relates to stable, multi-dose liquid compositions containing proteins, in particular, but not exclusively stable antibodies, and to the use of said compositions in therapy, in particular for the subcutaneous delivery of said stable protein.
    Type: Grant
    Filed: October 31, 2017
    Date of Patent: November 17, 2020
    Assignee: Novo Nordisk A/S
    Inventors: Henrik Parshad, Dorthe Kot Engelund
  • PROPYLENE GLYCOL-CONTAINING PEPTIDE FORMULATIONS WHICH ARE OPTIMAL FOR PRODUCTION AND FOR USE IN INJECTION DEVICES
    Publication number: 20200316204
    Abstract: The present invention relates to pharmaceutical formulations comprising a peptide and propylene glycol, to methods of preparing such formulations, and to uses of such formulations in the treatment of diseases and conditions for which use of the peptide contained in such formulations is indicated. The present invention further relates to methods for reducing the clogging of injection devices by a peptide formulation and for reducing deposits on production equipment during production of a peptide formulation.
    Type: Application
    Filed: June 24, 2020
    Publication date: October 8, 2020
    Inventors: Tina Bjeldskov Pedersen, Claude Bonde, Dorthe Kot Engelund
  • Propylene Glycol-Containing Peptide Formulations which are Optimal for Production and for Use in Injection Devices
    Publication number: 20190231876
    Abstract: The present invention relates to pharmaceutical formulations comprising a peptide and propylene glycol, to methods of preparing such formulations, and to uses of such formulations in the treatment of diseases and conditions for which use of the peptide contained in such formulations is indicated. The present invention further relates to methods for reducing the clogging of injection devices by a peptide formulation and for reducing deposits on production equipment during production of a peptide formulation.
    Type: Application
    Filed: January 29, 2019
    Publication date: August 1, 2019
    Inventors: Tina Bjeldskov Pedersen, Claude Bonde, Dorthe Kot Engelund
  • Stable Multi-Dose Compositions Comprising an Antibody and a Preservative
    Publication number: 20180104335
    Abstract: The invention relates to stable, multi-dose liquid compositions containing proteins, in particular, but not exclusively stable antibodies, and to the use of said compositions in therapy, in particular for the subcutaneous delivery of said stable protein.
    Type: Application
    Filed: October 31, 2017
    Publication date: April 19, 2018
    Inventors: Henrik Parshad, Dorthe Kot Engelund
  • Stable Antibody Containing Compositions
    Publication number: 20180000935
    Abstract: The invention relates to stable and low viscous (<50 cP) protein containing compositions, in particular, but not exclusively stable antibody containing compositions and to the use of said stable proteins in therapy, in particular for the subcutaneous delivery of said stable protein.
    Type: Application
    Filed: September 20, 2017
    Publication date: January 4, 2018
    Inventors: Henrik Parshad, Dorthe Kot Engelund, Malin Therese Gustavsson
  • Stable antibody containing compositions
    Patent number: 9795674
    Abstract: The invention relates to stable and low viscous (<50 cP) protein containing compositions, in particular, but not exclusively stable antibody containing compositions and to the use of said stable proteins in therapy, in particular for the subcutaneous delivery of said stable protein.
    Type: Grant
    Filed: February 28, 2011
    Date of Patent: October 24, 2017
    Assignee: Novo Nordisk A/S
    Inventors: Henrik Parshad, Dorthe Kot Engelund, Malin Therese Gustavsson
  • Stable formulation of modified GLP-1
    Patent number: 8846618
    Abstract: Pharmaceutical formulations of GLP-1 compounds and methods for preparation thereof.
    Type: Grant
    Filed: May 24, 2010
    Date of Patent: September 30, 2014
    Assignee: Novo Nordisk A/S
    Inventors: James M. Flink, Silke Møller Larsen, Simon Bjerregaard Jensen, Dorthe Kot Engelund
  • Stable formulations of peptides
    Patent number: 8748376
    Abstract: Stable pharmaceutical composition comprising insulinotropic peptide.
    Type: Grant
    Filed: December 21, 2009
    Date of Patent: June 10, 2014
    Assignee: Novo Nordisk A/S
    Inventors: Svend Ludvigsen, Morten Schlein, Tine Elisabeth Gottschalk Bøving, Claude Bonde, Anne-Mette Lilleøre, Dorthe Kot Engelund, Bjarne Rønfeldt Nielsen
  • Stable Multi-Dose Compositions Comprising an Antibody and a Preservative
    Publication number: 20130136733
    Abstract: The invention relates to stable, multi-dose liquid compositions containing proteins, in particular, but not exclusively stable antibodies, and to the use of said compositions in therapy, in particular for the subcutaneous delivery of said stable protein.
    Type: Application
    Filed: May 26, 2011
    Publication date: May 30, 2013
    Applicant: NOVO NORDISK A/S
    Inventors: Henrik Parshad, Dorthe Kot Engelund
  • Stable Antibody Containing Compositions
    Publication number: 20130028907
    Abstract: The invention relates to stable and low viscous (<50 cP) protein containing compositions, in particular, but not exclusively stable antibody containing compositions and to the use of said stable proteins in therapy, in particular for the subcutaneous delivery of said stable protein.
    Type: Application
    Filed: February 28, 2011
    Publication date: January 31, 2013
    Applicant: Novo Nordisk A/S
    Inventors: Henrik Parshad, Dorthe Kot Engelund, Malin Therese Gustavsson
  • PROPYLENE GLYCOL-CONTAINING PEPTIDE FORMULATIONS WHICH ARE OPTIMAL FOR PRODUCTION AND FOR USE IN INJECTION DEVICES
    Publication number: 20120225810
    Abstract: The present invention relates to pharmaceutical formulations comprising a peptide and propylene glycol, to methods of preparing such formulations, and to uses of such formulations in the treatment of diseases and conditions for which use of the peptide contained in such formulations is indicated. The present invention further relates to methods for reducing the clogging of injection devices by a peptide formulation and for reducing deposits on production equipment during production of a peptide formulation.
    Type: Application
    Filed: January 31, 2012
    Publication date: September 6, 2012
    Applicant: Novo Nordisk A/S
    Inventors: Tina Bjeldskov Pedersen, Claude Bonde, Dorthe Kot Engelund
  • Soluble pharmaceutical compositions for parenteral administration comprising a GLP-1 peptide and an insulin peptide of short time action for treatment of diabetes and bulimia
    Patent number: 8158583
    Abstract: Pharmaceutical composition for parenteral administration comprising a meal related insulin peptide and an insulinotropic peptide.
    Type: Grant
    Filed: May 12, 2009
    Date of Patent: April 17, 2012
    Assignee: Novo Nordisk A/S
    Inventors: Liselotte Bjerre Knudsen, Kristian Tage Hansen, Dorthe Kot Engelund, Svend Ludvigsen, Lars Hansen, Claude Bonde, Ejvind Jensen, Tine Elisabeth Gottschalk Bøving, Morten Schlein
  • Propylene glycol-containing peptide formulations which are optimal for production and for use in injection devices
    Patent number: 8114833
    Abstract: The present invention relates to pharmaceutical formulations comprising a peptide and propylene glycol, to methods of preparing such formulations, and to uses of such formulations in the treatment of diseases and conditions for which use of the peptide contained in such formulations is indicated. The present invention further relates to methods for reducing the clogging of injection devices by a peptide formulation and for reducing deposits on production equipment during production of a peptide formulation.
    Type: Grant
    Filed: May 17, 2006
    Date of Patent: February 14, 2012
    Assignee: Novo Nordisk A/S
    Inventors: Tina Bjeldskov Pedersen, Claude Bonde, Dorthe Kot Engelund
  • STABLE FORMULATION OF MODIFIED GLP-1
    Publication number: 20100234299
    Abstract: Pharmaceutical formulations of GLP-1 compounds and methods for preparation thereof.
    Type: Application
    Filed: May 24, 2010
    Publication date: September 16, 2010
    Applicant: NOVO NORDISK A/S
    Inventors: JAMES M. FLINK, SILKE MØLLER LARSEN, SIMON BJERREGAARD JENSEN, DORTHE KOT ENGELUND
  • Stable Formulations of Peptides
    Publication number: 20100173844
    Abstract: Stable pharmaceutical composition comprising insulinotropic peptide.
    Type: Application
    Filed: December 21, 2009
    Publication date: July 8, 2010
    Applicant: Novo Nordisk A/S
    Inventors: Svend Ludvigsen, Morten Schlein, Tine Elisabeth Gottschalk Boving, Claude Bonde, Anne-Mette Lilleore, Dorthe Kot Engelund, Bjarne Ronfeldt Nielsen